#ACLF
PLEX with low-dose corticosteroids showed encouraging short-term survival and improved severity scores in severe AAH-related ACLF.

Promising—but controlled trials are still needed.

#Hepatology #ACLF #AlcoholAssociatedHepatitis #PLEX #LiverDisease #ClinicalEvidence #MedSky
November 16, 2026 at 9:09 AM
Global multisociety consensus sets a unified framework for defining, diagnosing, grading and managing acute-on-chronic liver failure (ACLF), building on regional definitions, with standardised endpoints for future phase II/III trials.
Acute-on-chronic liver failure: A global multisociety consensus on definitions
Guideline · J Hepatol. Summary of the abstract on Y (askwhy.science).
askwhy.science
November 18, 2026 at 10:15 AM
"Achieving consensus on the definition of [acute-on-chronic liver failure] improves the generalizability of research across the globe"
Global Liver Societies Agree on One Definition of ACLF
Five international liver societies have reached a global consensus on the definition of acute-on-chronic liver failure, which will affect research and, eventually, patients.
www.medscape.com
November 10, 2026 at 7:33 PM
🌎 A unified global approach to acute-on-chronic liver failure #ACLF!

Published in HEPATOLOGY, a new framework from AASLD and four international liver societies aligns ACLF diagnosis, management, liver transplantation, and research.

📗 https://bit.ly/4BulOK1
October 30, 2026 at 2:26 PM
Amyl & The Sniffers are playing which will interest a few of you. Are Asleep At The Wheel there? Of course they bloody are. I think they might have played every ACLF since 2002. Remember what I learned you last year: a violin has strings, and a fiddle's gawt strangs.
www.youtube.com/watch?v=YTsD...
Miles and Miles of Texas
YouTube video by Asleep At The Wheel - Topic
www.youtube.com
October 2, 2026 at 11:58 PM
Day 2 of MICROB-PREDICT's Final #GeneralAssembly:

🩺 ALB-TRIAL wrap-up, #biomarkers, #POC biosensors & key decisions on data, #IP + exploitation 👩‍🔬

🫶 A heartfelt thank you to SEAB member Prof. Tilman Sauerbruch for his unwavering support throughout the years!

#cirrhosis #ACLF
@medblab.bsky.social
September 29, 2026 at 4:50 PM
📣 “If the project were a child, it would be in school by now!”

🥳 Jonel Trebicka opened #MICROB-PREDICT's Final GA Meeting today, looking back on 7 years of research, 100+ publications & major achievements.

Now it’s time for the final push! 🔬👏

#ACLF #cirrhosis #microbiome
@medblab.bsky.social
September 28, 2026 at 6:20 PM
The Global ACLF Consensus: the ‘Istanbul Document’

CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
September 26, 2026 at 1:15 PM
🔬💊A-TANGO has officially ended – but the G-TAK study continues!

Our final newsletter highlights the project's achievements, dissemination activities & new publications: mailchi.mp/1600401b049d...

The commitment to advance G-TAK beyond A-TANGO and help #cirrhosis & #ACLF patients remains strong. 💪
Final A-TANGO Newsletter - September 2026
A-TANGO has come to an end now - It was an international, collaborative Horizon 2020 research project to fight decompensated cirrhosis and develop an effective treatment for acute-on-chronic liver fai...
mailchi.mp
September 25, 2026 at 9:53 AM
Kenoh demonstrates the lariat for a martial artist who wants to adapt a pro-wrestling move for use in martial arts! 🤼

www.youtube.com/watch?v=AClf...
September 9, 2026 at 8:13 PM
The comprehensive, standardized framework provided by the APASL ACLF Beijing Position Paper takes a big step towards improving outcomes globally for critically sick patients with acute-on-chronic liver disease.

Find out more 👉️ buff.ly/XXGuEnP

#GISky #ACLF
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper
The comprehensive, standardized framework provided by the APASL ACLF Beijing Position Paper takes a big step towards improving outcomes globally for critically sick patients with acute-on-chronic…
www.springermedicine.com
August 27, 2026 at 10:54 AM
🔬 A prospective multicenter study explores plasma metabolites as tools to identify bacterial infection in acute-on-chronic liver failure. @isth.org
#ACLF #Infection
🔗 www.xiahepublishing.com/2310-8819/JC...
Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study
Bacterial infection is a key cause of mortality in patients with acute-on-chronic liver failure (ACLF). In this study, we aimed to identify metabolite biomarkers and develop a novel machine learning model for early identification of bacterial infection in ACLF.
www.xiahepublishing.com
August 24, 2026 at 3:30 PM
Highlights of #terlipressin aka #terlivaz label are it’s limitations of use:
. Cr >5 unlikely to benefit
. Volume overloaded or those with 3 or more organ failures (ACLF-3) at high risk for respiratory failure
. Do not give is spO2 is or becomes under 90% #LiverTwitter
December 2, 2024 at 11:45 PM
Hypophosphatemia in my experience, is by far the most challenging electrolyte imbalance to “fix” in an inpatient with ACLF. Any tricks of the trade other than the obvious!? #livertwitter
December 2, 2024 at 5:37 PM
Not planning to attend @AASLDtweets #TLM24 ?
Join @OHIOLIVER for our annual liver meeting update. Speakers include @aderlinder @metrohealthCLE and a special state of the art lecture on #ACLF by @CLindenmeyerMD @ClevelandClinic
#livertwitter
December 2, 2024 at 3:03 PM
February 2, 2025 at 2:05 AM
Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF #SingleCell 🧪🧬🖥️
http://medrxiv.org/cgi/content/short/2025.02.04.25321370v1
February 8, 2025 at 5:43 PM
First year as part of the EASL Task Force for Nurses and Allied Health Professionals done! My tasks included lecturing on nutrition in the palliative disease course, chairing a session on multiprofessional treatment of ACLF, and leading a workshop on PROMs and PREMs. So much fun! #EASLcongress
May 10, 2025 at 11:35 AM
Nice to see Kavish Patidar recognizing our work led by Paige McLean Diaz on RRT decision-making in transplant ineligible patients at #TLM24. Is it time to trial serious illness communication & TLT interventions in the ACLF space? #palliativehepatology #LiverSky #NephSky @juancarlosqvelez.bsky.social
November 18, 2024 at 8:49 PM
So good to see you ( and everyone!) at the ACLF, Tania! Until the next time!
December 18, 2024 at 7:20 PM
Next was an interesting talk by Umakanth Varottil on the phenomenon of Indian companies flipping incorporation to Singapore and back, with commentary by @akamalnath.bsky.social at ECGI www.youtube.com/watch?v=Yl4Q... (5/8)
ACLF 2026 | Flipping Companies Across Borders: An Asian Perspective
YouTube video by ECGI
www.youtube.com
May 28, 2026 at 10:08 PM
Next was an excellent talk by Mutsuhiko Yukioka on the evolving landscape of corporate takeovers in Japan, with commentary by Nydia Remolina at the European Corporate Governance Institute (ECGI) www.youtube.com/watch?v=bAQM... (3/8)
ACLF 2026 | The Evolving Landscape of Corporate Takeovers in Japan
YouTube video by ECGI
www.youtube.com
May 28, 2026 at 10:08 PM
Wei Zhang and Xu Yan, with discussion by Umakanth Varottil - red-chip companies going private - www.youtube.com/watch?v=phQw... (4/7)
ACLF 2026 | A Tale of Two Jurisdictions: Red-Chip Companies Going Private
YouTube video by ECGI
www.youtube.com
May 25, 2026 at 8:42 PM
Ishana Tripathi, with commentary from Dan W. Puchniak - succession plans for Indian listed companies - www.youtube.com/watch?v=rYS0...

Haemin Lee, Ishana Tripathi, and Xingguang Zou - emerging issues in corporate governance - www.youtube.com/watch?v=BcHm... (3/7)
ACLF 2026 | Scope of succession plans for listed companies in India – A case study
YouTube video by ECGI
www.youtube.com
May 25, 2026 at 8:42 PM